Little Green Pharma Ltd (ASX: LGP) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Little Green Pharma Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $130.97 million
P/E Ratio 4.95
Dividend Yield N/A
Shares Outstanding 235.94 million
Earnings per share -0.073
Dividend per share N/A
Year To Date Return 30.09%
Earnings Yield 20.19%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Little Green Pharma Ltd (ASX: LGP)
Latest News

LGP ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Little Green Pharma Ltd

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. Its business activities include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products.The company offers LGP-branded medicinal cannabis oil products in the Australian market.

LGP Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
16 Sep 2021 $0.74 $-0.01 -1.35% 477,727 $0.74 $0.74 $0.72
15 Sep 2021 $0.74 $-0.03 -3.90% 679,453 $0.77 $0.77 $0.74
14 Sep 2021 $0.77 $0.01 1.31% 224,389 $0.76 $0.78 $0.76
13 Sep 2021 $0.77 $-0.01 -1.30% 212,556 $0.78 $0.78 $0.77
10 Sep 2021 $0.77 $0.01 1.32% 284,949 $0.77 $0.80 $0.77
09 Sep 2021 $0.76 $-0.02 -2.58% 784,217 $0.81 $0.82 $0.75
08 Sep 2021 $0.78 $-0.04 -4.91% 667,464 $0.82 $0.82 $0.77
07 Sep 2021 $0.82 $0.05 6.54% 1,687,097 $0.76 $0.84 $0.76
06 Sep 2021 $0.77 $0.03 4.05% 630,317 $0.75 $0.77 $0.75
03 Sep 2021 $0.74 $-0.01 -1.34% 199,538 $0.75 $0.76 $0.73
02 Sep 2021 $0.75 $-0.01 -1.33% 732,200 $0.76 $0.78 $0.73
01 Sep 2021 $0.75 $0.04 5.59% 267,893 $0.72 $0.75 $0.72
31 Aug 2021 $0.72 $-0.01 -1.39% 491,775 $0.70 $0.75 $0.70
30 Aug 2021 $0.72 $0.00 0.00% 330,198 $0.70 $0.72 $0.69
27 Aug 2021 $0.72 $0.02 2.86% 204,058 $0.71 $0.72 $0.71
26 Aug 2021 $0.70 $-0.01 -1.42% 162,647 $0.71 $0.71 $0.70
25 Aug 2021 $0.71 $0.01 1.44% 44,906 $0.70 $0.71 $0.70
24 Aug 2021 $0.70 $-0.01 -1.43% 266,734 $0.70 $0.72 $0.70
23 Aug 2021 $0.70 $0.01 1.44% 155,970 $0.70 $0.71 $0.70
20 Aug 2021 $0.70 $-0.01 -1.43% 371,284 $0.70 $0.71 $0.69
19 Aug 2021 $0.70 $-0.01 -1.42% 383,914 $0.71 $0.72 $0.70
18 Aug 2021 $0.71 $-0.03 -4.08% 894,737 $0.73 $0.73 $0.70

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
06 Sep 2021 Neale Fong Issued 35 $26,775
Issue of securities. 260,458 - Retention Share Rights & Director Share Rights
06 Sep 2021 Michael Lynch-Bell Issued 70 $53,550
Issue of securities. 370,000 - Retention Share Rights
17 Aug 2021 Angus Caithness Issued 1 $1,102,500
Issue of securities. 2,500,000 - Performance Rights
17 Aug 2021 Fleta Solomon Issued 1 $1,102,500
Issue of securities.
12 Mar 2021 Fleta Solomon Issued 40 $22,363
Conversion of securities.
12 Mar 2021 Fleta Solomon Issued 614 $430,301
Conversion of securities.
12 Mar 2021 Fleta Solomon Exercise 614 $430,301
Conversion of securities. 1,000,000 - Performance Rights
12 Mar 2021 Fleta Solomon Exercise 40 $22,363
Conversion of securities. 1,000,000 - Performance Rights
As per announcement on 12/03/2021.
12 Mar 2021 Neale Fong Exercise 41 $22,742
Conversion of securities. 225,458 - Retention Share Rights & Director Share Rights
As per announcement on 12/03/2021.
12 Mar 2021 Neale Fong Issued 41 $22,742
Conversion of securities.
12 Mar 2021 Angus Caithness Exercise 615 $430,861
Conversion of securities. 1,000,000 - Performance Rights
As per announcement on 12/03/2021.
12 Mar 2021 Angus Caithness Issued 71 $39,420
Conversion of securities.
12 Mar 2021 Angus Caithness Exercise 71 $39,420
Conversion of securities. 1,000,000 - Performance Rights
As per announcement on 12/03/2021.
12 Mar 2021 Angus Caithness Issued 615 $430,861
Conversion of securities.
12 Mar 2021 Michael Lynch-Bell Exercise 82 $45,485
Conversion of securities. 368,091 - Retention Share Rights
12 Mar 2021 Michael Lynch-Bell Exercise 150 $105,641
Conversion of securities. 300,000 - Retention Share Rights
As per announcement on 12/03/2021.
12 Mar 2021 Michael Lynch-Bell Issued 150 $105,641
Conversion of securities.
12 Mar 2021 Michael Lynch-Bell Issued 82 $45,485
Conversion of securities.
17 Dec 2020 Neale Fong Issued 225 $133,020
Director remuneration. 225,458 - Share Rights
17 Dec 2020 Angus Caithness Issued 115 $68,154
Director remuneration. 2,115,516 - Share Rights & Performance Rights
As per announcement on 17/12/2020.
17 Dec 2020 Michael Lynch-Bell Issued 450 $266,041
Director remuneration. 450,917 - Share Rights
17 Dec 2020 Fleta Solomon Issued 114 $67,682
Director remuneration. 1,614,716 - Share Rights & Performance Rights

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Neale William Fong Non-Executive Director Nov 2018
Dr Fong has over 35 years in senior leadership roles in private hospitals, the public health systems, management consulting, academia, health research, aged care and not for profit organisations. He is currently Chair of the Western Australian Government Country Health Service Board, Professor of Healthcare Leadership at Curtin University, Executive Chairman of Bethesda Health Care and a Director of a number of health-related start-up companies. He is an experienced ASX company Director including a former Non-Executive Director of Neurotech International Limited (ASX:NTI) and executive chair of Chrysalis Resources Limited (ASX:CYS). He was formerly Director General of the Western Australian Department of Health and CEO of St John of God Hospital in Perth. Neale was awarded the Centenary Medal in 2011 for services to healthcare by the Australian Government.
Mr Angus McDougall Caithness Executive Director Feb 2018
Mr Caithness is an experienced corporate finance executive and consultant in Australia and international markets. Angus has ASX experience as a Non-Executive Director of Lindian Resources Limited (ASX:LIN), CFO of Hunnu Coal (ASX:HUN) and Company Secretary for the IPO of Haranga Resources (ASX:HAR). Following these roles, Angus acted as CFO of Erdenes Tavan Tolgoi, the owner of the coking coal deposit. Angus was previously an Executive Director at EY in London and Australia focusing in initial public offerings of mining companies. Angus is a Harvard Business School alumnus and is currently completing a Master of Science
Ms Fleta Jennifer Solomon Managing Director May 2017
Ms Solomon has 17 years' experience in corporate and consumer health markets. Over ten years, Fleta established, grew and sold one of Australia's providers of workplace health services. She has since been involved in several start-ups including a water treatment technology business and a digital health engagement company based in Singapore.
Mr Michael David Lynch-Bell Non-Executive ChairmanNon-Executive Director Nov 2018
Mr Lynch-Bell is an experienced corporate finance executive and consultant. His early Ernst & Young career was focused on auditing clients within the oil and gas sectors and later added mining to his portfolio. Michael also led Ernst & Young's UK IPO and Global Natural Resources transaction teams in the Transaction Advisory practice. He has been involved advising companies on fundraising, re-organisations, transactions, corporate governance as well as IPOs. Michael is a former Chair of the Bureau and current member of UNECE's Expert Group on Resource Measurement and a non-executive Director of Barloworld Limited (JSE:BAW), Senior Independent Director and Remuneration Committee Chair of Gem Diamonds Limited (LSE:GEMD), Audit Committee Chair of Lenta Limited (LSE:LNTA) (MCX:LNTA) and Deputy Chair and Nomination Committee Chair of Kaz Minerals plc (LSE:KAZ).
Mr Alistair Warren Company Secretary Jul 2020
-
Alistair Warren Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Elixxer Ltd 25,045,896 18.72%
Ms Fleta Jennifer Solomon 19,600,000 14.65%
Banquo Consulting Pty Ltd 5,500,000 4.11%
Hsbc Custody Nominees (Australia) Limited-Gsi Eda 3,913,238 2.93%
Hsbc Custody Nominees (Australia) Limited 3,258,423 2.44%
National Nominees Limited 3,154,178 2.36%
Mutual Trust Pty Ltd 2,772,251 2.07%
Tr Nominees Pty Ltd 2,656,264 1.99%
Tiga Trading Pty Ltd 2,255,187 1.69%
Ms Jenny Lorraine Mckay 2,016,669 1.51%
Corpserv Pty Ltd 1,700,000 1.27%
Benoni Pty Ltd 1,684,000 1.26%
Ms Mary Bernadette Davis 1,337,500 1.00%
Mr Sean Edward Reid + Ms Louise Jane Pilkington 1,272,600 0.95%
Heavenly Star Pty Ltd 1,250,000 0.94%
Pfl Green Growth Pty Ltd 1,111,111 0.83%
Yaselleraph Finance Pty Ltd 1,105,160 0.83%
Interdale Pty Ltd 1,009,889 0.75%
Lipsmackers Pty Ltd 1,000,000 0.75%
UBS Nominees Pty Ltd 1,000,000 0.75%

Profile

since

Note